1.8
İlaç-Reseptör Etkileşimleri
İlaç-reseptör etkileşimi, reseptörlerin ilaçlar tarafından bağlanmasını tanımlar, ancak tüm ilaç-reseptör etkileşimleri aktivasyon ve doku tepkisi ile…
Bir ilaç, konformasyonel değişiklikleri indükleyerek veya hücresel bir yanıt oluşturmak için efektör molekülleri işe alarak reseptörünü aktive eder. Bununla birlikte, tüm ilaçlar bağlandıktan sonra hedeflerini veya reseptörlerini aktive etmez.
İlaç bağlanması, ilacın reseptöre olan afinitesine bağlıdır. Düşük konsantrasyonlarda bile, yüksek afiniteli ilaçlar, maksimum reseptör doluluğu için endojen ligandlarla rekabet eder.
Bir ilacın etkinliği, hücresel bir yanıt ortaya çıkarma yeteneğini belirler. İlaçlar, afinite ve etkinliklerine göre agonistler, kısmi agonistler veya antagonistler olarak kategorize edilir.
Bir agonist, maksimum bir yanıt ortaya çıkarmak için reseptörü aktive eder. Agonistler, bir reseptörün aktivitesini arttırmak için endojen bir ligand bağlanma bölgesine veya ayrı bir allosterik bölgeye bağlanabilir. Reseptörlerin toplam doluluğu olmasa bile, bir agonistin etkinliği yaklaşık% 100 kalır.
Kısmi bir agonist orta düzeyde etkinliğe sahiptir ve %100 reseptör doluluğunda bile sadece submaksimal bir yanıt üretebilir.
Son olarak, bir antagonist, reseptörü bağlamak ve etkisiz hale getirmek için endojen ligand ile rekabet eder. Bu nedenle, antagonist ihmal edilebilir bir etkinliğe sahiptir ve bir yanıt üretmez.
View the full transcript and gain access to JoVE Core videos
Q1: What is the difference between drug affinity and drug efficacy?
Drug affinity is the ability of a drug to bind to its receptor, determining how readily it occupies receptor sites even at low concentrations. Efficacy is the drug's ability to activate the receptor and elicit a cellular response. High-affinity drugs compete effectively with endogenous ligands for receptor occupancy, while efficacy determines whether that binding produces a maximal, submaximal, or negligible response.
Q2: How do agonists activate receptors to produce a cellular response?
Agonists activate receptors by inducing conformational changes or recruiting effector molecules that generate a cellular response. They can bind to the endogenous ligand binding site or a separate allosteric site to increase receptor activity. Agonists have high affinity and nearly 100% efficacy, producing maximal responses even without total receptor occupancy.
Q3: Why do partial agonists produce submaximal responses despite full receptor occupancy?
Partial agonists have intermediate efficacy, meaning they cannot fully activate receptors even when bound to all available receptor sites. Unlike agonists with nearly 100% efficacy, partial agonists are intrinsically limited in their ability to generate a cellular response. This reduced efficacy results in submaximal tissue responses regardless of complete receptor occupancy.
Q4: What mechanism allows antagonists to block drug responses?
Antagonists compete with endogenous ligands and agonists for receptor binding sites, stabilizing the receptor in an inactive state. They have negligible efficacy and do not produce a response themselves. By occupying receptors, antagonists prevent agonists from binding and activating the receptor, effectively blocking the cellular response.
Q5: How do allosteric antagonists differ from pharmacologic antagonists?
Pharmacologic antagonists compete directly with other molecules for the same receptor binding site and stabilize the receptor in an inactive state. Allosteric antagonists bind to separate sites on the receptor and change the affinity and efficacy of agonists without competing for the primary binding site. Both reduce receptor activation but through distinct mechanisms.
Q6: Why is understanding drug-receptor binding essential for predicting drug effects?
Drug-receptor interactions determine whether a drug activates or inactivates its target, directly influencing tissue response. The drug's affinity, efficacy, and binding mechanism—whether at the agonist site or allosteric site—collectively determine its pharmacological effect. Understanding these interactions is critical for predicting how factors affecting drug response will influence therapeutic outcomes.
Q7: What determines whether a drug will be classified as an agonist, partial agonist, or antagonist?
Drug classification depends on two parameters: affinity and efficacy. Agonists have high affinity and high efficacy, producing maximal responses. Partial agonists have high affinity but intermediate efficacy, producing submaximal responses. Antagonists have variable affinity but negligible efficacy, producing no response. These properties determine the drug's functional effect on tissue.